SCHEMBL4037998

SCHEMBL4037998

Cc1ccccc1OCC(=O)Nc1ccc(OCCN2CCCCC2)c(-c2ccnn2C)c1

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 20/20 0.73
HTR2C P28335 18/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4041233 0.99 HTR2A (0.71) HTR2AHTR2C
SCHEMBL4120511 0.93 HTR2A (0.68) HTR2AHTR2C
SCHEMBL4214483 0.91 HTR2A (0.68) HTR2AHTR2C
SCHEMBL4207693 0.91 HTR2A (0.75) HTR2AHTR2C
SCHEMBL4042172 0.91 HTR2A (0.75) HTR2AHTR2C
SCHEMBL4037413 0.90 HTR2A (0.74) HTR2AHTR2C
SCHEMBL3944658 0.90 HTR2A (0.78) HTR2AHTR2C
SCHEMBL14385273 0.89 HTR2A (0.76) HTR2AHTR2C
SCHEMBL4228882 0.88 HTR2A (0.77) HTR2AHTR2C
SCHEMBL4041361 0.87 HTR2A (0.79) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051978-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-04-29 EP claimed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO claimed
EP-2051978-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-04-29 EP disclosed
WO-2007136875-A2 ACETAMIDE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO disclosed